Myoconda (clarithromycin/clofazimine/rifabutin) - RedHill
RHB-104: FDA meeting related to P3 trial design and path to approval in Crohn's disease in mid-2019 (RedHill) - May 16, 2019 - Corporate Presentation 
FDA event
https://ir.redhillbio.com/static-files/7b018c0b-a4fc-4e51-a03b-0c904dfa206e
 
May 16, 2019
 
 
c57c0b69-cd45-4bac-b6bc-87a9b9c82c70.png